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Abstract
Background: Although Differentiated Service Delivery (DSD) for anti-retroviral therapy (ART) has been rolled-out
nationally in several countries since World Health Organization (WHO)‘s landmark 2016 guidelines, there is little
research evaluating post-implementation outcomes. The objective of this study was to explore patients’ and HIV
service managers’ perspectives on barriers to implementation of Differentiated ART service delivery in Uganda.
Methods: We employed a qualitative descriptive design involving 124 participants. Between April and June 2019
we conducted 76 qualitative interviews with national-level HIV program managers (n = 18), District Health Team
leaders (n = 24), representatives of PEPFAR implementing organizations (11), ART clinic in-charges (23) in six
purposively selected Uganda districts with a high HIV burden (Kampala, Luwero, Wakiso, Mbale, Budadiri, Bulambuli).
Six focus group discussions (48 participants) were held with patients enrolled in DSD models in case-study districts.
Data were analyzed by thematic approach as guided by a multi-level analytical framework: Individual-level factors;
Health-system factors; Community factors; and Context.
Results: Our data shows that multiple barriers have been encountered in DSD implementation. Individual-level:
Individualized stigma and a fear of detachment from health facilities by stable patients enrolled in community-
based models were reported as bottlenecks. Socio-economic status was reported to have an influence on patient
selection of DSD models. Health-system: Insufficient training of health workers in DSD delivery and supply chain
barriers to multi-month ART dispensing were identified as constraints. Patients perceived current selection of DSD
models to be provider-intensive and not sufficiently patient-centred. Community: Community-level stigma and
insufficient funding to providers to fully operationalize community drug pick-up points were identified as
limitations. Context: Frequent changes in physical addresses among urban clients were reported to impede the
running of patient groups of rotating ART refill pick-ups.
Conclusion: This is one of the first multi-stakeholder evaluations of national DSD implementation in Uganda since
initial roll-out in 2017. Multi-level interventions are needed to accelerate further DSD implementation in Uganda
from demand-side (addressing HIV-related stigma, community engagement) and supply-side dimensions
(strengthening ART supply chain capacities, increasing funding for community models and further DSD program
design to improve patient-centeredness).
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Background
In Sub-Saharan Africa (SSA), it is common to find that
HIV clinics are heavily congested with long patient
queues. Long waiting times are typical at HIV clinics
and health workers endure heavy workloads [1–7]. Due
to the widespread overcrowding and the resource-
constrained operational contexts of HIV clinics in SSA,
innovations in HIV service delivery approaches have
become imperative [1–7]. Differentiated Service Delivery
(DSD) is one such innovation. DSD has been defined as
‘a client-centered approach that simplifies and adapts
HIV services across the cascade, in ways that both serve
the needs of people living with HIV better and reduce
unnecessary burdens on the health system’ [2].
In 2016, DSD was endorsed by the World Health
Organization (WHO) and leading global HIV donors such
as Presidents’ Emergency Plan for AIDS Relief (PEPFAR)
and The Global Fund to Fight AIDS, Tuberculosis and
Malaria (The Global Fund) as a novel evidence-informed
HIV service delivery approach that relieves pressure on
over-burdened health systems in SSA [2]. In addition to
improving health-system efficiencies, tailoring HIV care to
the needs of individual clients as, opposed to ‘one-size-
fits-all’ undifferentiated models of care, has been proven
to improve patient outcomes and the quality of HIV care
[1–4]. DSD embraces patient-centric approaches that seek
to reduce unnecessary burdens of care on patients which
results in savings in the time spent at facilities and the
transport costs associated with more frequent visits to
facilities [4]. As shown in Fig. 1, Duncombe and col-
leagues [7] posit that these innovative HIV service
delivery alternatives constitute elements that entail a
reduction in service intensity and frequency for stable
patients, task shifting to non-clinical health worker
cadre and changes in service location (such as co-
opting community-based platforms).
Since 2017, several countries in SSA have been imple-
menting DSD. Some of the countries rolling-out DSD
nationally include Kenya, Uganda, Malawi and Zambia [8].
National DSD implementation in Uganda
In 2016, Uganda released updated national ART treatment
guidelines providing for DSD in alignment with WHO
treatment guidelines released the same year [9]. In 2017,
PEPFAR, the predominant HIV donor in Uganda [6],
included national DSD roll-out in its annual program tar-
gets for Uganda known as Country Operational Plan
(COP 2017) [10]. As illustrated in Fig. 2, Uganda is cur-
rently implementing two broad categories of DSD models:
i) Facility-based models and ii) Community-based models
[9]. Figure 2 shows the five specific DSD models currently
in implementation in Uganda. The facility-based models
are three; i) Facility Based Individual Management (FBIM),
ii) Facility Based Group (FBG) and iii) Fast-Track Drug
Refill (FTDR). There are two community-based models; i)
Community Drug Distribution Points (CDDP) and ii)
Fig. 1 Duncombe et al.(2015)’s ‘Four levers to tailor or adapt HIV care to people’s needs
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Community Client-Led ART Delivery (CCLAD) [10].
Uganda is widely considered as a leader in DSD im-
plementation because it was one of the first countries
to provide for DSD in its national ART treatment
guidelines as well in rolling it out nationally [11, 12].
Uganda therefore presents a unique opportunity of
generating implementation research lessons with po-
tential for broader application to other countries with
a high HIV burden, especially those in resource-
limited settings. By April 2019, the Ministry of Health
and donors were training health workers in DSD de-
livery with almost 67% of health facilities covered
across the country [12]. These on-going health worker
trainings have also targeted select ‘expert’ patients or
HIV client ‘peer leaders’ [12]. In Uganda, PEPFAR
subsidiary local and international non-governmental
organizations known as ‘implementing partners’ have
also been mandated by PEPFAR to spearhead DSD
roll-out at the sub-national level in geographic re-
gions under their purview [10].
Most of the evidence on patient perspectives on Differ-
entiated ART services has been drawn from clinical trials
or controlled research settings [5, 7, 8, 13]. Although DSD
has been rolled-out nationally in several countries since
WHO’s landmark 2016 guidelines were released, there is a
dearth of evidence on patient perspectives on HIV care
under DSD in ‘real world’ settings or at the frontline level
of service delivery [14–16]. A notable exception is a study
conducted in Ghana [17]. However, that study only re-
ported patient experiences of DSD from one tertiary
hospital in Cape Coast Ghana. There is little research
reporting post-implementation perspectives of patients
and frontline health workers following national scale-up
of DSD models in resource-limited settings [8].
Fig. 2 The five Differentiated Service Delivery models in implementation in Uganda. Source: Ministry of Health, Implementation Guide for
Differentiated Service Delivery Models of HIV and TB Services in Uganda (June 2017)
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Research reporting patient perspectives on DSD and their
preferences is critical in further program design of DSD
models which is still an evolving process [3, 8, 14–16].
Although DSD is an encompassing term that usually incor-
porates differentiated HIV testing and treatment, in this
paper we focus on antiretroviral therapy (ART) delivery.
ART constitutes one of the highest unit costs of HIV care
and holds enormous promise of maximizing efficiency
gains via DSD [4]. We particularly focus on patients
deemed clinically stable on ART and are enrolled in DSD
models through appointment spacing, multi-month ART
dispensing, community drug pick-up points and patient
support groups [3, 6]. Although national DSD implementa-
tion has been ongoing in Uganda since 2017, there have
been little research evaluating implementation outcomes
since initial roll-out. The objective of this study was to
explore patients’ and HIV service managers’ perspectives
on barriers to implementation of DSD for ART following a
national scale-up program in Uganda.
Methods
Study design
This study employed a qualitative descriptive design
aimed at understanding patients’ and HIV service man-
agers’ perspectives on barriers to implementation of
DSD for ART in Uganda. We aimed to explore the bar-
riers to uptake of Differentiated ART service delivery
models from the perspectives of participants within the
context(s) underpinning their interface with the health
system [18]. We utilized a case-study research design,
which is recommended for in-depth investigation of
complex phenomena [19].
Analytical framework
This study is broadly guided by an analytical framework
proposed by Levesque and colleagues [20] which is
based on a systematic review that was conducted on fac-
tors influencing access to health care. This analytical
framework proposes a multi-level lens incorporating
both demand-side (individual-level factors such as know-
ledge, attitudes, and self-care practices) and supply-side
factors (health-system factors such as availability of
human resources and financing, enabling policies and
physical infrastructure) in understanding influences on
access to health care. The Levesque framework guided
the study in two ways. We deliberately sought multi-
stakeholder perspectives on DSD implementation which
informed the diversity and range of the study partici-
pants selected. Secondly, the framework guided data
analysis by providing an overarching deductive thematic
framework in which to categorize our inductively-
generated sub-themes presented in the results sections.
Study sites and sample selection
In keeping with the multi-level analysis lens of the adopted
analytical framework [20] of the study, multi-stakeholder
participants were purposively selected to represent the pro-
grammatic, provider and patient perspectives on DSD im-
plementation in Uganda at the national, sub-national and
facility-levels (Table 1). Participants were drawn from
national-level HIV program managers at the Ministry of
Health’s AIDS Control Program (ACP), District Health
Team leaders and representatives of PEPFAR implement-
ing organizations. At the facility-level, we interviewed ART
clinic in-charges and their staff as well as patients enrolled
in Differentiated ART delivery models. We purposively se-
lected health facilities in Uganda to achieve diversity with
regard to a) ownership-type (public/private) b) level of care
in the Ugandan health system and c) setting (rural/urban).
The demographic characteristics of participating health fa-
cilities are shown in Table 2. Participating health facilities
were drawn from the Central and Eastern regions of
Uganda from six districts with a relatively high HIV burden
and with a dense concentration of ART sites from which
we could purposively sample (Central: Kampala, Wakiso,
Luwero, Eastern: Mbale, Bulambuli, Manafwa).
We aimed to understand patient perspectives of HIV
care under the various DSD models being implemented
in Uganda. We sought to elicit patient perspectives on
the challenges of enrolling in these novel ART delivery
models through focus group discussions (FGDs) involv-
ing individuals enrolled in the same DSD models. As
such, FGDs were deemed appropriate as they enabled a
diversity of responses and allowed us to explore varia-
tions in patient experiences under the same DSD models
[21]. For these FGDs, patients were eligible to participate
if they had been enrolled in at least one of the DSD
models currently on offer in Uganda (Fig. 2). Patients
were enrolled if they had been accessing care in a DSD
model for at least a year and voluntarily consented to
eliciting experiences of HIV care under Differentiated
ART delivery. We selected adults who were at least 18
years of age and were willing to offer written informed
consent to participate in the study.
Data collection
A topic guide was constructed around themes derived
from the analytical framework adopted for the study
Table 1 Category of participants (n = 124)
1. National-level HIV program managers 18
2. District health team leaders 24
3. PEPFAR ‘implementing partner’ representatives.
(Local and international non-government organizations)
11
4. ART clinic in-charges and staff 23
5. Participants in patient focus group discussions 48
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[20]. These include: i) Individual-level factors e.g. know-
ledge, attitudes, self-care practices ii), Health-system fac-
tors e.g. Human resources, financing, policy iii) Setting
e.g. influence of urban setting on choice of care as sug-
gested by the Levesque framework [20]. This topic guide
(supplementary file) was used to guide both our qualita-
tive interviews and FGDs.
Overall, 23 semi-structured interviews (SSIs) were
conducted with ART clinic in-charges and their staff
across the case-study health facilities (Table 2). The aim
of the interviews was to understand barriers to DSD im-
plementation from a facility-level dimension and to ex-
plore health workers’ perspectives on the national scale-
up of Differentiated ART services. Face-to face inter-
views were conducted in participants’ offices within the
health facilities between April and June 2019. The inter-
views were conducted by the first author who holds a
PhD in health systems and has an academic background
in the social sciences and an expertise in qualitative re-
search [22, 23]. The first author was assisted by three
Research Assistants (RAs) experienced in qualitative
health services research.
In addition, 53 semi-structured interviews (SSIs) were
conducted with select participants with unique ‘insider’
knowledge on Uganda’s national DSD implementation
planning and processes. These include national-level
HIV program managers at Uganda’s Ministry of Health
(n = 18), 24 District Health Team leaders (including Dis-
trict Health Officers or DHOs) and representatives of
PEPFAR implementing organizations in case-study dis-
tricts (n = 11) with unique knowledge of DSD implemen-
tation at sub-national level. The interviews were aimed
at understanding the programming and policy dimen-
sions of DSD implementation from national and sub-
national perspectives of influential actors in the health
system in Uganda whose actions influence the adoption
of public health interventions. On average, these inter-
views lasted between 40 and 60 min.
In total, we conducted six focus groups discussions with
each involving eight participants (Table 2). The focus group
discussions were conducted on the designated ART clinic
day at each of the case-study facilities when patients
attended facilities for scheduled reviews. Participants were
selected with the help of the ART clinic-charge based on a
declared inclusion criterion. We explained the objectives of
the research to all study participants including the nomi-
nated patients attending scheduled reviews at the ART
clinics who were invited to participate on a voluntary basis.
Written informed consent was obtained before focus
groups could commence discussions. The focus groups
were facilitated by the first author who was assisted by
three RAs. The RAs took notes to ensure accuracy in tran-
scription [21]. On average, the FGDs lasted 1 hour.
Data capture and analysis
We followed the processes recommended for ensuring
rigour in case-study and qualitative data analysis suggested
by Gilson, L et al. (2011) (Table 3) [24]. We made audio re-
cordings of all of the interviews and then transcribed each
interview verbatim. In terms of data analysis procedures,
we followed four major steps. However, this was a largely
iterative process [25]. The first step involved data
familiarization through multiple readings of interview tran-
scripts by HZ, JR and JK [25]. The second step entailed gen-
erating a coding framework. Codes were inductively
generated from the interview transcripts in a team-based
process involving four authors (HZ, JR, JK, CK). The
third stage was that of abstracting the coded data into
thematic categories. The emergent inductive or data-
driven codes were then grouped under a deductive
thematic framework based on items selected from
Levesque’s framework [20]: i) Individual-level factors
ii), health-system factors iii) Community and iv) Con-
textual factors. Hence, our coding combined both in-
ductive and deductive analysis approaches [26]. This
process involved three authors (HZ, JR, and JK). The
fourth and final step was that of Interpretation and
overall synthesis. A multi-stakeholder data validation
workshop was conducted in June 2019 at which the
initial study findings were presented. We invited eight
national-level HIV program managers, 12 District
Health Team leaders, 16 ART clinic in-charges and
11 patients ‘peer’ leaders to this one-day data valid-
ation workshop. The authors made a one-hour pres-
entation of the study findings and invited comments
and feedback from participants. Participants’ feedback
informed the final analyses. All authors were involved
in the overall synthesis of the study findings which
Table 2 Characteristics of participating health facilities
PUB-01 PUB-02 PUB-03 PUB-04 PFP-01 PNFP-01
Ownership-type Public Public Public Public For-profit Not for profit






Clinic (HC III) Health centre III
Urban setting Urban Urban Peri-urban Rural Urban Rural
HIV services offered VCT, ART, PMCT VCT, ART, PMCT VCT, ART, PMCT VCT, ART, PMCT VCT, ART VCT, ART
Key: PMTCT Prevention of mother to child transmission services, VCT Voluntary counselling and testing of HIV
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were arrived at through a consensus process that re-
solved disagreements in interpretation [24, 25].
Results
The findings emerging from this study are presented
based on themes derived from the analytical framework
advanced by Levesque and colleagues [20] described
above. The broad themes proposed were individual-level,
health-system, community and contextual factors.
Individual-level factors
Focus group discussions with patients and interviews
with HIV service managers revealed multiple individual-
level barriers to enrollment in Differentiated ART deliv-
ery models in Uganda. These include internalized stigma,
fears of detachment from the health system and limited
patient literacy about Differentiated Service Delivery.
Internalized HIV-related stigma
Our findings show that internalized stigma is a funda-
mental barrier to enrollment in community-based DSD
models due to patient fears of breach of confidentiality
of their HIV sero-status which would be inadvertently
disclosed to all members of a patient group to which an
individual belongs. Individual fears of involuntary dis-
closure of HIV status to peers was frequently cited as an
impediment to enrollment in DSD models across our
focus groups with patients and interviews with health
workers. As one patient said:
‘Patients don’t want to join CCLAD groups because
they say ‘so and so will get to know that I have HIV’.
So, the lines are still long at my hospital because
people still live in fear to come out and join patient
groups for picking their medicines because they think
if you take for him ARVs then you will tell somebody
else who was not aware of their HIV status. So
people still have that fear’ Patient, FGD, PUB-01.
Fear of detachment from the health-system
Numerous patients who were enrolled in community-
based DSD models expressed a fear of detachment from
the formal health-system. The majority of these recipi-
ents of care were deemed stable on ART and hence did
not have a clinical need to make monthly visits to HIV
clinics. Several patients in the FGDs described deriving
psychosocial support in regular face-to-face interactions
with health workers. Some patients also expressed per-
sonal attachment to individual health workers who they
had grown accustomed to meeting monthly for sched-
uled reviews. Patients frequently expressed fears that
prolonged periods without being seen by health workers
would imply inability to access comprehensive care in-
cluding in the event of opportunistic infections such as
Tuberculosis (TB).
‘When the clients are given drugs for three months,
one may get an attack like TB or another opportun-
istic infection so it may take long for health workers
to discover. When you are in the CDDP groups you
feel you are no longer part of the health system.
Sometimes you sit there and think, they took us to
the community to die from there’ Patient FGD,
PNFP-01.
Table 3 Processes for ensuring rigor in case-study analysis
adapted from Gilson et al. (2011)
PRINCIPLE
Prolonged engagement We spent 2–3 weeks at each of the
six case-study facilities. Multiple
on-site visits were spent engaging
in informal discussions with ART
clinic in-charges.
Use of theory The analytical framework by
Levesque et al. (2013) which
proposes a multi-level perspective
on factors affecting access to
health care guided our analysis
of the study findings.
Case selection Six health facilities were
purposefully selected in areas
of Uganda with a relatively high
HIV burden and a concentration
of ART sites to enable purposive
sampling.
Sampling We aimed to have a sample that
had appropriate representation
of health facility demographics
in Uganda with respect to a)
setting (rural/urban), b) ownership-
type (public, for-profit, not-for-
profit), c) Level of care (tertiary,
secondary, primary).
Multiple methods Multiple methods were used
including face-to-face interviews,
focus group discussions (FGDs)
and informal engagements with
clinicians and ART Clinic in-charges.
Triangulation Case descriptions were
constructed based on
triangulation across multiple
data sources (Interviewee data
and document review).
Negative case analysis Emergent themes/ findings that
contradicted initial assumptions
were identified.
Peer debriefing and support Data analysis at each of the four
major stages involved a team-
based process involving at least
three authors.
Respondent validation A multi-stakeholder data validation
workshop was conducted at which
the initial study findings were
presented. Participant feedback
informed the final analyses.
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Overall, our findings from FGDs reveal that the
majority of patients appeared to prefer facility-based
models to community-based DSD models. This no-
tion seemed to hold even among health workers.
Many health workers perceived FTDR to be the most
practical DSD model to implement hence patient en-
rollments were reported to be skewed as such.
Community-based DSD models, especially Commu-
nity drug pick points, were described as costly to
implement as they required fuel for transporting
health workers into communities to monitor patients
in this model of care, preparing pre-packaged ART
medicines and finding suitable physical infrastructure
to designate as community drug pick-up points in
remote, rural settings. Hence health-system con-
straints appeared to interact with individual-level
choices in influencing patient uptake of (especially)
community-based DSD models.
‘The enrollment in fast-track refill models is high
which is good because it is the easiest to implement
at the facility level in my opinion. The guidelines are
very clear, two viral loads and you are stable, no
problems, it’s easy’ ART clinic in-charge, PUB-01.
The national-level HIV program managers reported
national statistics on patient enrollment in DSD models
that appear to corroborate our qualitative findings.
‘Currently, facility-based models account for the big-
gest proportion of enrollment in DSD models. Fast-
Track Drug Refills stand at 38%, Facility-Based
Groups are at 9% and Community Client-Led ART
Delivery are at 7%. Nevertheless, the Ministry of
Health is very optimistic about seeing more
utilization of community models’ National-level,
HIV program manager.
Contrary to what has been reported in the literature, a
number of patients discounted the advantages associated
with reduced frequency of visits to facilities such as re-
ported savings in time and transport costs. Health
workers reported that although patients are frequently
sensitized about the advantages of enrolling in less-
intensive DSD models during their visits to the facilities
for clinical reviews, some patients expressed a willing-
ness to meet the costs of frequent visits to facilities espe-
cially those in urban settings.
‘Who told you I don’t have transport money to come
here (at health facility) every month? For me I am
prepared and ready to pay my 10,000 Uganda shil-
lings ($ 2.74) every month to come here to pick my
drugs’ Patient FGD, PUB-02.
‘When it comes to DSD we are not on the same page
with patients. Although DSD confers several advan-
tages to patients such as savings in time spent at fa-
cilities and a reduction in transport costs incurred in
seeking care, patients have other considerations
which we have found to be contrary to our expecta-
tions’ ART clinic in-charge, PNFP-01.
Health workers at two participating facilities (PUB-01,
PUB-02) reported increasing cases of patients requesting
self-referrals to especially private health facilities (many
of which had not yet started implementing Differentiated
ART delivery) on account of their reluctance to join pa-
tient groups especially involuntary ones initiated by
health workers in some facilities.
Low patient literacy of DSD models
Low patient literacy of DSD models was a recurring
theme across our interviews with health workers and in
our FGDs with patients. It emerged that patients had
not been sufficiently sensitized on the merits of enroll-
ment in DSD models and there remained demand-side
gaps in knowledge and awareness about DSD.
‘As a client in Kampala, I rarely hear mention of
DSD at my facility. Even my fellow clients don’t
know about DSD. That is a fact. As a peer-leader, if
I tell them about DSD they have not seen it in prac-
tice’ Patient FGD, PUB-03.
National-level HIV program managers reported that
there was a section of patients across Uganda who had
not yet been reached by national DSD sensitization
drives and community engagement efforts across the
country which were reported to be on-going. Our inter-
views revealed that where DSD community-engagement
drives had been conducted in Uganda they had targeted
only a section of health workers and patient ‘peer-
leaders’ who had not yet widely disseminated to the
broader base of patients at health facilities.
‘Some of the patients have not heard about DSD,
but this not surprising because we have not yet
reached 100% of health facilities. Even in the Cen-
tral Region, not all facilities have been trained.
When we do facility-based trainings, the patients
that we actually reach are the peer leaders’
National-level HIV program manager.
The national-level HIV program managers reported
that increased health education talks for patients had
been followed by increased DSD uptake including
community-based models.
Zakumumpa et al. BMC Health Services Research          (2020) 20:222 Page 7 of 16
‘Facilities where sensitization has happened, you see
that the uptake not only for the facility-based but
even the community models goes up because then
patients appreciate why they should actually join’
National-level HIV program manager.
One emergent finding from our interviews with health
workers was that patient preference of DSD models was
partly influenced by their socio-economic status. Specif-
ically, health workers reported observing trends suggest-
ing that some urban clients with relatively high income
preferred facility-based individual models due to a per-
ceived higher need of privacy and confidentiality. Lower-
income individuals especially those who couldn’t afford
monthly transport costs of about 10,000 Uganda shil-
lings (US$ 2.7) were said to prefer community-based
models such as CDDP because they enabled them to
make savings in transport costs.
‘What we are seeing is that patients who are better
off (financially) decline joining community groups
such as CCLAD and CDDP because they crave priv-
acy and prefer to receive individualized care at the
health facility. But the reverse is true of our poorer
and rural clients who prefer community models such
as CDDP which reduce their transport costs’ ART
clinic in-charge, PUB-02.
Health-system factors
Health worker competence in DSD delivery
Health worker competence in DSD was revealed as a
bottleneck in service implementation in our sample of
health facilities. National-level HIV program managers
revealed that some health facilities had health workers
who had not yet been trained in DSD delivery while for
those facilities which had been reached by DSD training
programs of the Ministry of Health, only a proportion of
their health workers in the ART clinics had been trained
in DSD delivery. Interviews with national-level HIV pro-
gram managers revealed that 67% of health facilities
across Uganda had been covered by the national pro-
gram on health worker training in DSD service delivery.
‘Currently, we have trained health workers in 1,200
(out of 1,800) health facilities providing ART in
Uganda. They have been engaged and trained on
DSD implementation. Only 600 facilities are yet to
be covered’. National-level HIV program manager.
Our findings in Eastern Uganda suggest that health
worker trainings in DSD delivery did not necessarily
translate into implementation. This was particularly the
case in lower-level health facilities especially those at the
county (Health Centre IVs) and sub-county (Health
center IIIs) levels. Multiple implementation barriers were
cited that include insufficient funding for running
community-based DSD models.
Frequent stock-outs
Frequent ART medicines stock-outs were highlighted as
a recurring bottleneck in implementing DSD models
particularly the FTDR and CDDP models. Across our in-
terviews with health workers and focus groups with pa-
tients it was revealed that clients, in some case-study
facilities, were getting one-month or even a two-week
supply of anti-retrovirals (ARVs) owing to frequent
stock-outs. Participants confirmed that there were
country-wide ARVs stock-outs in the last quarter of
2018 which impeded multi-month refills which are a
cornerstone of Differentiated ART delivery.
‘Drug stock outs are a big challenge. We had stock-
outs in the last quarter of 2018 and the first quarter
of 2019. Those of us on fast-track drug refills, instead
of being given a three-month supply, we were getting
one month and even two weeks at one point. So, how
will we sustain the model?’ Patient FGD, PUB, 002.
DSD not implemented in lower health facilities
We observed variations in DSD implementation by level
of care in the Ugandan health system. In our sample of
health facilities from Eastern Uganda, DSD implementa-
tion was reported to have commenced at the tertiary-
level (regional and district hospitals). However, partici-
pating lower-level health centers (sub-district and sub-
county health centers) indicated they hadn’t yet imple-
mented DSD.
‘DSD is being rolled out at the level of tertiary hospi-
tals and not yet at lower level health centers. Al-
though some facilities have been trained in DSD
services, they have not gone ahead to implement.
The training was done but the implementation has
not yet taken place because of so many issues’ ART
clinic in-charge, PFP-01.
In our FGDs at sub-district public facilities in Eastern
Uganda, patients indicated that some of their peers had
heard about DSD although several of them had not yet
been enrolled into DSD models. We found a handful of
centers of excellence in HIV care such as The AIDS
Support Organization (TASO) where a majority of their
patients were enrolled in DSD models.
‘DSD is not a totally a new concept. It was named
DSD but you will notice that in Uganda, we had
already done differentiation. People were coming
after every two months, after three months and in
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some places, like the centers of excellence like TASO.
Actually, most of our learning around DSD was from
TASO, they had already initiated the community
drug distribution points’ National-level HIV pro-
gram manager.
“Unstable’ as a stigmatizing label
Patients perceived the terms used in DSD nomenclature
of ‘unstable’ and ‘stable’ as provider stigma. Although
the terms ‘unstable’ or ‘stable’ denote clinical assessment
of whether patients are doing well on treatment or not
and therefore their eligibility for the various DSD
models, patients expressed disapproval of the use of the
term ‘unstable’.
‘Using the term ‘unstable’ and ‘stable’, to me and I
think to some of us, that language is stigmatizing. If you
tell me that John you are ‘unstable’, I will feel down. I
feel that is unfair to me’ Patient FGD, PUB-01.
Interviews with health workers revealed that prior to
the introduction of DSD nomenclature in Uganda’s na-
tional ART guidelines of 2016, ART-providing organiza-
tions had devised more acceptable in-house terms to
refer to ‘stable’ and ‘unstable’ patients. This included the
use of colors to indicate a patient’s clinical status such as
those suppressing and those not suppressing. Health
workers maintained that DSD was not an entirely new
approach in Uganda and that they had originally devised
terms that were more patient-sensitive before the intro-
duction of new nomenclature following country-wide
DSD roll-out.
‘Where I get care they call it a ‘pink card’. When you
get a pink card it means you are stable, you do not
need to see a doctor all the time and people really
strive to earn that card. They even call their doctor
and say ‘doctor, I have got a pink card and I am so
happy’. It is like a graduation’ Patient FGD, PUB-003.
‘In Uganda, these are not the words we use because
when you go to Buganda (central Uganda), they
have simplified the ‘stable’ and ‘unstable’ by using
local language alternatives. You get it? But our no-
menclature in English of defining this person who is
not suppressing is wanting. I understand and appre-
ciate patient concerns’ National-level HIV program
manager.
DSD is not client-centered
Patients and health workers concurred in relaying the
notion that although DSD was intended to be a client-
centered, current DSD delivery especially decisions on
assignment of DSD models were intensely provider-
directed and patients did not meaningfully participate in
making decisions regarding which DSD models in which
to be enrolled. Although clinical criteria are paramount
in patient differentiation, focus groups with patients re-
vealed that their individual preferences were rarely put
into consideration in assessing their readiness for a par-
ticular DSD model.
‘Patients are just told that “you, you will be getting
drugs from your community”. We are told that it is
client –centred but is it? Clients should be involved
in making decisions about their care’ Patient FGD.
National-level HIV program managers revealed a need
to engender client-centeredness in the curricula of the
on-going health worker DSD trainings across Uganda
and to the need to provide opportunity for the participa-
tion of patients in DSD program design and the further
refinement of these models.
‘We are trying to build the capacity of health
workers in letting them know that groups that are
self-formed are groups that are going to last. We
have seen instances where the health workers go
ahead and prescribe and two months down the road,
everybody they put in that group is no longer there.
Because they practically push them there’ National-
level HIV program manager.
Clash between DSD and tuberculosis appointment spacing
An important finding of this study is that patients en-
rolled in DSD models such as those enrolled in the
FTDR model or those receiving multi-month ART refills
but who were also on TB management, were still ex-
pected to make monthly visits to the health facility re-
gardless of whether they were stable on both ART and
TB. Both health workers and patients perceived this as a
practice that undermines the intended benefits of differ-
entiated care of reducing burdens on patients who are
clinically stable.
‘TB is one of the new areas that is coming up. How
do we do differentiation for TB services? For ex-
ample, you are giving preventive therapy of isoniazid
for one month and yet this person who is stable on
ART gets their review every 6 months, how do we
reconcile these two?’ ART clinic in-charge, PUB-03.
A few of the patients in our focus groups, particu-
larly older HIV patients with co-morbidities especially
Non-Communicable Diseases (NCDs) such as hyper-
tension and diabetes reported that their NCDs condi-
tions were being managed separately from their HIV
care needs and the benefits of reducing the frequency
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of clinic visits were not being realized for them des-
pite DSD implementation.
‘I am 63 years old and I have been on ART for
eleven years. Last year during a routine check they
found I had both pressure (hypertension) and sugar
(diabetes). Now, I have to visit the Diabetes clinic
every month yet I am stable on ART and visit the
HIV clinic once every three months’. Patient FGD,
PUB-01.
‘We have clients who are in the age groups of 50 and
above, most of them due to cohort ageing, have
NCDs and it gets difficult to have these people get
into the drug refill programs the more you have a
mature cohort the more you have other problems
coming up’ Health worker, PUB-01.
Community-level factors
National-level HIV program managers reported that pa-
tient enrollment in community-based DSD models
across the country stood at between 5 and 7%. Partici-
pants reported that community DSD models were beset
by multiple constraints ranging from HIV-related stigma
to insufficient funding for operationalizing these models
across Uganda.
‘Enrollment in community-based models is at about
5-7%. We need to see more involvement of stable pa-
tients in community-based models which is where
everybody should be comfortable to avoid congesting
health facilities when they are well’ National-level
HIV program manager.
Community-level stigma
Across our interviews with health workers and focus groups
with patients, stigma within communities stood out as a
critical barrier to realizing the full potential of DSD in re-
lieving pressure on over-burdened health facilities.
‘Community models are not very popular with cli-
ents. One of the reasons cited is stigma. Patients in
many health facilities prefer to receive care at the
health facilities because they are afraid of stigma
from other community members. You know when
you join a CCLAD group of ten people, all those ten
people will now know your HIV status. And these
are people who live in your neighborhood, in your
village. Stigma is really a big challenge’. ART clinic
in-charge, PUB-01.
‘As we implement these models, it is incumbent upon
us to regard stigma as a key issue. Stigma is a key
challenge which is still exists in our communities.
This is what I have found during the on-site supervi-
sions of DSD that I have conducted. Patients prefer
to stay at the facility because of stigma within the
community’ National-level HIV program manager.
Implementation challenges associated with community-
based DSD models
Health workers reported that several challenges had
been encountered in implementing community-based
DSD models. The CDDP model was frequently de-
scribed by ART clinic in-charges as one that required
substantial financial and human resources to implement.
The challenges elicited include the need for vehicles and
fuel to transport health workers into communities to de-
liver ART refills. The need for health worker monetary
allowances during community visits and the difficulty in
finding suitable physical infrastructure in rural settings
to designate as outreach points for ART refills. With re-
gard to the CCLAD model, the financial costs of off-site
monitoring of stable patients within communities was
identified. The difficulty of finding competent and liter-
ate leaders of CCLAD groups within client populations
was frequently raised.
‘The problem we face is that most CCLAD groups
are failing. You find that you need to be 3-6 mem-
bers in a group that resides in the same location.
You may find that all the six members are illiterate.
They can’t read, they can’t write and none is willing
to take lead and when you are a leader, you need to
do some documentation. So that has been a chal-
lenge for us’ Patient FGD, PUB-04.
Group leaders of patient groups expressed difficulty in
sustaining transport costs to facilities to pick drugs on
behalf of their colleagues. Although picking drugs from
the facility was meant to be a rotating responsibility
among group members, it was common to find that, in
many of the groups, the burden was frequently shoul-
dered by a single member.
‘Most of our clients come from hilly places they
spend about 10,000 shillings ($ 2.7) to and from. So,
I told them, if we form a group of 10 members, in-
stead of each one of us spending 10,000 you can give
10,000 to one person we have selected to go pick our
medicines. They accepted but I remain with that
transport burden alone. My income is very little yet I
have to support this group’ Patient FGD, PUB-04.
Leaders of CCLAD groups who pick drugs from health
facilities on behalf of their members reported difficulty
in identifying ART refill packages for each of their
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individual members. Delivering incorrect drug packages
to their members was reported to happen in some in-
stances as narrated in the quote below:
‘There are challenges in identifying individual drugs
for members of the CCLAD patient group. I can be a
group leader delivering drugs to other clients but you
realize someone says ‘they have packed for so and so
different ARVs, yet he takes a different regimen’ Pa-
tient FGD, PNFP-01.
Health workers decried the additional workload in-
volved in packaging and labelling ARVs drug packages
for each individual member in models involving
decentralization of drug delivery to communities. In
high-volume facilities, the number of patient (CCLAD)
groups were said to be as many as 40. Since each of
these patient groups had an average membership of six
members, the burden of preparing ART refill packages
had increased workloads. This was a notion frequently
raised by health workers and HIV service managers.
‘Labelling drug packages for those on multi-month
scripts is a headache. You need to indicate on the
bottles that these drugs are for month number one,
and this is month is for month number two and
three. So, if you have 6,000 clients in DSD models
that shows just how much work you have to put in
packing drugs and correctly labelling them for each
and every individual’ ART clinic in-charge, PUB-01.
Insufficient funding for implementing community models
A common refrain from the health workers was the in-
sufficient funding for operationalizing community-based
DSD models. The CDDP model was frequently cited as
an example of community-based models that require
substantial funding to implement. Health workers men-
tioned the need for constant fuel for health workers to
travel outside of the health facilities into the communi-
ties to monitor patients, transport for ferrying ART re-
fills into communities and the difficulty of finding
suitable physical space in remote communities to desig-
nate as drug pick-up points. A concern that was fre-
quently raised by health workers was that of the
sustainability of community-based DSD models, such as
CDDP which are currently heavily donor-dependent.
National DSD scale-up in Uganda has depended sub-
stantially on PEPFAR funding since initial roll-out in
2017. Participants perceived facility-based DSD models
as more sustainable in the event of loss of donor sup-
port. We observed a widely-held perception that com-
munity DSD models were expensive to implement and
unsustainable without international assistance.
‘I think that the best DSD models should remain the
facility-based ones because it is not sustainable going
into these communities. You are able to deliver these
medicines now just because there is donor funding
but time is going to come when there is no funding’
ART clinic in-charge, PUB-02.
Contextual factors
Overall, our interviews with health workers and FGDs
with patients appeared to relay the notion that setting
was influential on the uptake of individual DSD models.
In our sample of health facilities, patients hailing from
urban settings expressed preference for facility-based in-
dividual models over community-based models.
‘There are certain unique issues in urban areas like
in Kampala (capital city). People do not want to
form groups. They just want to go to the facility, get
their drugs and go home, or go to a point somewhere
to get their drugs and then go home’ PEPFAR Imple-
menting organization representative.
Mobility among urban clients
Health workers of case-study facilities located in urban
settings reported that patients frequently changed resi-
dential addresses. The dynamic nature of their urban pa-
tients was said to impede the smooth running of self-
formed patient groups (such as CCLAD) which require
stable populations that reside in the same physical loca-
tion for them to thrive.
‘How do you constitute the groups especially in
Kampala (capital city) which is dynamic because
people keep moving and frequently change residen-
tial addresses? It has been difficult’. ART clinic in-
charge, PUB-01.
Our focus groups revealed that HIV-related stigma
was especially pronounced in urban settings and patients
in case-study facilities located in urban areas expressed a
reluctance to form groups with peers who lived in close
physical proximity. This was raised as one of reasons
why patients formed inconvenient groups of individuals
(CCLAD) living in disparate locations for fear of breach
of confidentiality of their HIV status with recipients of
care living in the same neighborhood.
‘The CCLAD approach is not working as well as an-
ticipated due to stigma especially in urban areas.
Patients form inconvenient groups with people living
in different areas because of stigma. You will find
groups where one client is from Kawempe (North of
the capital) forming with a client from Nakawa
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(East of the capital) and may be Makindye (South of
the capital) and they will choose a place in the city
center where they will receive their drugs’ Represen-
tative of PEPFAR implementing organization.
Participants from a case-study facility in the Ugandan
capital Kampala reported that HIV-related stigma im-
peded the running of community ART refill pick-up
points and they were compelled to devise alternative dis-
tribution points through private retail pharmacy net-
works in Kampala.
‘What we did in Kampala in collaboration with the
National Drug Authority is to just make patients
pick their medicines from a nearby (retail) pharmacy
because they are not interested in forming groups,
they are not interested in doing anything else so they
just go to a nearby pharmacy, pick their drugs and
in ten minutes they are out’ PEPFAR Implementing
organization representative.
Discussion
Although several countries in Sub-Saharan Africa have
been implementing countrywide DSD roll-out since
2017, there is a dearth of evidence on early program im-
plementation outcomes [27]. This is one of the first
multi-stakeholder evaluations of national DSD imple-
mentation in Uganda since its initial roll-out in 2017. In
this study, participants reported that they had encoun-
tered multiple implementation barriers in the adoption
of DSD from both a demand-side and supply-side di-
mension of the health system [20]. Specifically, from the
demand-side perspective, barriers to enrollment in DSD
models relate to individualized stigma and a fear of de-
tachment from the formal health-system for stable pa-
tients enrolled in community-based models. In this
study, health workers reported that lower-income and
rural patients prefer community-based DSD models
while urban and financially wealthier patients tended to
prefer facility-based models due to a higher expressed
need for privacy and confidentiality. From a supply-side
perspective, participants raised multiple logistical com-
plexities and implementation challenges. These include
frequent stock-outs which undermined multi-month
ART prescribing and insufficient funding for operation-
alizing community DSD models such as outreach drug
pick-up points. Patients perceived the assignment of
DSD models as not sufficiently patient-centred.
Our study illuminates the diverse preferences of pa-
tients and underscores the notion that there is no ‘one
size fits all’ DSD model due to the varying needs and
characteristics of patients which are influenced by a var-
iety of factors, which, in this study, we found, include
socio-economic status and the rural-urban dynamics of
setting. A study from South Africa published in 2019
[28] found that that community-based DSD models did
not work for everyone. There has been broad acknow-
ledgement in the literature that with regard to differenti-
ated HIV care, patients’ preferences are complex and
that further research is warranted to better understand
this phenomenon [2–4, 8, 14, 29–31]. We call for future
research to explore whether socio-economic status and
rural-urban setting have a bearing on patient choice of
DSD models especially if such studies use large samples
of patients.
Contrary to what has been reported in the literature
about the benefits realized by patients such as savings in
transport costs and time spent at facilities via DSD when
compared to more intensive undifferentiated care models
[13, 17, 28, 32] our findings suggest that the picture is
more complex and patients have other considerations in
the models of HIV care they prefer. For instance, some pa-
tients in our study sample, preferred frequent clinic visits
with a few expressing a willingness to spend money and
time despite awareness of the benefits of DSD in reducing
the burden of treatment. We found that stable patients
enrolled in community models feared a detachment from
health facilities and felt that they would not receive
comprehensive care and treatment in the event of oppor-
tunistic infections such as tuberculosis if they remained in
community-based models owing to their being catego-
rized as ‘stable’. Previous studies have highlighted the
psycho-social satisfaction patients derive from engaging
with health workers on a regular basis [33]. Adjetey and
colleagues [17] in a study in Ghana report that patients
preferred facility-based HIV services to community-based
care even after the government there had invested consid-
erably in the latter models.
From a supply-side or health-system dimension, our
study highlights the multiple implementation challenges
encountered in DSD roll-out across Uganda. The fre-
quent stock-out of ART medicines stood out in partici-
pant discourses which suggests that Uganda’s current
pharmaceutical supply chain architecture is not yet
attuned to the new levels of performance demanded by
DSD implementation such as multi-month ART dis-
pensing. At the level of human resources for health, we
found that health worker trainings in DSD delivery are
still on-going across the country which impedes DSD
coverage rates at health facilities in Uganda and poses
questions relating to the quality of DSD services cur-
rently on offer in Uganda. For instance, several patients
perceived current DSD delivery in case-study facilities
not to be sufficiently patient-centred. In this study, we
found a widely held perception among health workers,
and even national-level HIV program managers, that
some community-based models, particularly the CDDP
model, were expensive to implement and that current
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funding levels were insufficient to fully and widely
operationalize them [34, 35]. This calls for further re-
search around the cost effectiveness of select DSD
models using data from Uganda or similar settings. A
study by Sharer and colleagues [28] reports human re-
sources and financing challenges in national DSD imple-
mentation in South Africa. There has been broad
acknowledgment in the literature of health-system cap-
acity constraints in moving DSD from pilot to scale in
resource-constrained settings [3, 7, 8, 14, 36].
Policy and programming implications of our study
Our study has a number of policy and programming im-
plications for the Uganda government and donors. We
found that HIV-related stigma was a fundamental bar-
rier to patient enrollment in community-based models
of care. Our findings suggest that there is sub-optimal
implementation of community models and that the full
potential of DSD in decongesting clinics and reducing
workloads has not yet been realized in participating fa-
cilities. For donors such as PEPFAR, which funds imple-
menting organizations at the sub-national level in
Uganda, we found variations in DSD coverage in the dis-
tricts we sampled which may be suggestive of a need for
geographic prioritization in DSD scale-up efforts
through pivoting to geographic sub-regions that are lag-
ging behind. Devising stigma-reduction interventions
through counselling, health education campaigns and
sustained community engagement in Uganda are critical
to optimizing the efficiencies promised by differentiating
HIV care and treatment [36–38]. Some patients in our
study expressed dissatisfaction with the level of patient-
centeredness in current DSD delivery which may point
to the need to improve patient participation in decision
making in HIV care. This calls for increased engagement
of health workers through trainings aimed at enhancing
patient-centered HIV care as well as further research in
DSD program design to enhance this notion. Providers
called for increased funding from Uganda government
and donors to facilitate full operationalization of
community-based models such as facilitation for desig-
nating outreach sites for delivering drugs to stable pa-
tients [34]. Strengthening Uganda’s pharmaceutical
supply chain system to align with the new performance
demands imposed by multi-month scripting is a priority
that requires re-orienting policy and business process re-
engineering especially by the National Medical Stores
(NMS) and other actors along the ART medicines sup-
ply chain. Overall, our study suggests that national DSD
implementation is unlikely to follow a linear or ‘straight’
path as laid out in Uganda’s national DSD implementa-
tion guide but will require an iterative and dynamic pos-
ture that conforms more to the characteristics of a
‘complex adaptive system’ [39] approach in responding
to the multiple logistical complexities and implementa-
tion barriers. MacGregor and colleagues [40], in a study
in South Africa, found that moving ART adherence
clubs from pilot to scale in the South African health sys-
tem was wrought with ‘complexities’. They note that dif-
ferentiated HIV care innovations such as ART
adherence clubs on a ‘small scale’ appear ‘excellent’ but
when implemented on a ‘large scale’ challenges emerge.
Study implications for countries with similar setting as
Uganda
Our study has implementation research lessons for other
countries in resource-limited settings rolling out differ-
entiated ART models. Our study findings underscore the
enormity of demand-side barriers to enrollment in Dif-
ferentiated models of care which are often under-
explored in DSD scale-up efforts. Psycho-social barriers
such as HIV-related stigma are often under-explored in
national scale-up efforts with an over-emphasis on pro-
grammatic scale-up targets in spite of this critical bottle-
neck [31]. In a study in South Africa, Hanrahan and
colleagues [30] conclude that “we urge caution in assum-
ing that the effectiveness of clinic-based interventions
will carry over to community settings, without a better
understanding of patient-level factors associated with
successful retention in care”. A study in Malawi found
that frequent changes in the residential addresses of in-
dividual members of patient adherence support groups
impeded retention in community-based care platforms
[38]. On the ‘supply side’ dimension, our findings under-
score the importance of strengthening ART medicines
supply chains and policy changes to facilitate the
decentralization of dispensing into communities [8, 36].
There is need for deepening the capacity of suppliers for
managing the dramatic increase in demand or the sheer
volumes of ART medicines to be dispensed occasioned
by DSD implementations such as multi-month scripting
[7, 41]. Our findings point to the need for harmonizing
appointment spacing in HIV care with the management
of other co-morbidities such as diabetes and hyperten-
sion [42, 43]. We found that older patients (50 years and
above) who had well-controlled sugar levels or blood
pressure and were also stable on ART were still required
to make monthly clinic visits regardless of the DSD
provision of 3-monthly visits. This calls for the inte-
grated management of HIV and other co-morbidities
that is becoming increasingly important priority due to
ageing cohorts of clients and the need to revisit treat-
ment guidelines even in non-HIV services [42–44].
An important finding of this study is that socio-
economic status was perceived to have an influence on
patient selection of DSD models. We found that patients
who couldn’t raise the 10,000 Uganda shillings (US$ 2.7)
average direct cost of visiting facilities preferred
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community drug pick-up points and peer support in
sharing the transport costs associated with picking ART
refills from facilities. On the other hand, a select number
of urban patients expressed a preference for facility-
based individualized care and a willingness to meet the
costs associated with more frequent visits to facilities.
There is some support in the literature for this notion of
heterogeneity in patient preferences [16, 28, 31, 45, 46].
This may call for planning and programming that puts
the complex and diverse preferences of patients into
consideration in the quest to scale-up differentiated
models of HIV care.
Limitations
Our study has a number of limitations that we wish to
acknowledge. We utilized a case-study approach of six
health facilities in Uganda. Although this enabled us to
have an in-depth insight into DSD implementation at
the facility and community-levels, our study findings
may not be fully generalizable to all HIV service delivery
settings across Uganda [19].
Strengths
This study had several strengths which include a multi-
stakeholder lens into national DSD implementation in
Uganda incorporating actors at the programming, pro-
vider, policy and patient levels [18, 20]. Additionally, we
elicited national and sub-national level insights thus pro-
viding a more rounded perspective on the early imple-
mentation experiences of national DSD scale-up in
Uganda.
Conclusion
This is one of the first multi-stakeholder evaluations of
national DSD implementation in Uganda since its initial
roll-out in 2017. Multi-level interventions are needed to
accelerate further DSD implementation in Uganda from
both a demand-side perspective such as addressing HIV-
related stigma and community engagement to improve
DSD uptake and a supply-side dimension such as
strengthening ART supply chain capacities, increasing
funding for community DSD models and improving
DSD program design to embrace patient-centeredness.
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